Ozempic
-
Not all fiber is created equal, and one particular type – which is most highly concentrated in common breakfast oats – may trigger the same beneficial metabolic functions that GLP-1 agonists like Ozempic do, without the price tag or side-effects.
-
People living with diabetes might have a new hope. Scientists have tested a new drug therapy in diabetic mice, and found that it boosted insulin-producing cells by 700% over three months, effectively reversing their disease.
-
Being prescribed semaglutide for diabetes or weight management is associated with an increased risk, up to seven times, of developing a relatively rare form of untreatable blindness, sometimes referred to as an 'eye stroke,' a new study has found.
-
Semaglutide, better known as Ozempic and Wegovy, has added another string to its therapeutic bow. A recent international clinical trial found that it significantly reduced the risk of kidney failure and death in type 2 diabetics with chronic kidney disease.
-
The current breakthrough weight-loss drugs are only the beginning, according to Danish researchers hard at work on a new treatment that targets the brain's natural plasticity, which could offset bad side effects and provide more long-term benefits.
-
Amid ongoing global shortages of semaglutide, the active ingredient in medical sensations Ozempic and Wegovy, researchers have uncovered a way to make 10 times more of the stuff, producing a therapeutically similar version of the in-demand drug.
-
Next-gen anti-obesity drugs like injectable liraglutide, sold as Saxenda, deliver impressive results in the first 12 months. New research looks into what happens to those results once treatment stops.
-
In yet another surprise attribute of the new class of obesity drugs, scientists have found that GLP-1 receptor agonists can also subdue brain inflammation, giving them a potential ‘superpower’ in the fight against Alzheimer’s and Parkinson’s diseases.
-
New research found that patients taking the weight-loss and diabetes drug semaglutide had significantly reduced symptoms of alcohol use disorder. Larger studies are currently underway to see whether the drug is an effective treatment for addiction.
-
Research has found that signals linked to how food tastes are sent to our brains almost immediately to slow our eating pace, with the well-known stretch signals from the gut coming later, providing greater insights into how the body controls appetite.
-
Managing diabetes usually involves regular shots, but soon patients might only need injections a few times a year. Stanford has developed a hydrogel-based delivery system that slowly releases drugs over months to control diabetes and even weight.
-
The US has officially got a homegrown hero in the burgeoning global industry of effective weight-loss treatment, with the FDA approval of Lilly’s Zepbound. The company has revealed its cost, dosages, insurance subsidies and when it will be on shelves.